FDA orders new Nonoxynol-9 warning

Dec 18, 2007

The U.S. Food and Drug Administration issued a final rule Tuesday requiring manufacturers of nonoxynol-9, or N9, to add a warning to the product's label.

The FDA said the warning must state the over-the-counter vaginal contraceptive and spermicidal product does not protect against infection by the human immunodeficiency virus that causes AIDS, nor does it protect against other sexually transmitted diseases.

Stand-alone spermicides include gels, foams, films, or inserts containing N9 that are used by themselves for contraception.

The federal agency said consumers can protect themselves from the transmission of STDs and HIV by practicing abstinence, being in a monogamous relationship with an uninfected partner and by using condoms consistently and correctly.

The FDA said it issued the rule to correct misconceptions that the chemical N9 protects against sexually transmitted diseases, including HIV infection.

In addition, the FDA is requiring the labels warn consumers that N9 in stand-alone vaginal contraceptives and spermicides can irritate the vagina and rectum, which may increase the risk of contracting HIV/AIDS from an infected partner.

Copyright 2007 by United Press International

Explore further: Risks of taking paracetamol long-term may have been underestimated by clinicians

add to favorites email to friend print save as pdf

Related Stories

Tech companies eye security that goes beyond passwords

Jun 19, 2013

In late February, a thief or thieves cracked into Evernote's digital vault filled with log-ins, passwords and email addresses belonging to 50 million users. It was a shocking cyberattack considering the Redwood City, Calif., ...

HPV vaccination prevents genital warts in males

Feb 04, 2011

(PhysOrg.com) -- A new international study shows the human papillomavirus (HPV) vaccine protects against genital warts and other lesions associated with HPV in males. HPV is the most common sexually transmitted disease and ...

Recommended for you

Anticholinergic drugs linked to risk for pneumonia in elderly

22 hours ago

Taking commonly used medications with anticholinergic effects is associated with a significantly higher risk for developing pneumonia in a study of more than 3,000 older Group Health patients living in the community—not ...

Drug research and development more efficient than expected

Feb 27, 2015

Drug R&D costs have increased substantially in recent decades, while the number of new drugs has remained fairly constant, leading to concerns about the sustainability of drug R&D and question about the factors that could ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.